The Scottish Medicines Consortium (SMC) has published new advice accepting three new medicines for use by NHS Scotland, offering patients new treatment options for soft tissue sarcoma, acromegaly and hepatitis C
Read More
Patients with certain forms of lung cancer or sarcoma have now gained access to two new treatment options on the NHS in England after Merck’s Keytruda and Eli Lilly’s Lartruvo were added to the Cancer Drugs Fund.
Read More
Patients with soft tissue sarcoma in England and Wales look set to win routine NHS access to Eli Lilly’s Lartruvo after cost regulators backed funding for the drug in draft guidelines.
Read More
Eli Lilly’s Lartruvo has received a conditional marketing approval by the European Commission to treat soft tissue sarcoma (STS).
Read More
Eli Lilly’s Lartruvo has been approved by the US Food and Drug Administration to treat soft tissue sarcoma.
Read More
